Pliant Therapeutics, Inc.

8-K Director or officer change Jul 13, 2026 8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Director or officer change Apr 17, 2026 8-K Other events Mar 30, 2026 8-K Results of operations (earnings release) Mar 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 11, 2026 8-K Entered a material agreement; Modified rights of security holders Mar 3, 2026 8-K Director or officer change Dec 16, 2025 8-K Director or officer change Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change Oct 24, 2025 8-K Terminated a material agreement Oct 20, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Aug 7, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Exit or disposal costs; Director or officer change May 1, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Other events Feb 13, 2025 8-K Other events Feb 10, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Amended charter or bylaws Sep 27, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Other events Jul 15, 2024 8-K Director or officer change; Shareholder vote results Jun 14, 2024 8-K Other events May 14, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 8-K Results of operations (earnings release) May 6, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Mar 12, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Other events Feb 5, 2024